The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...
How Do You Treat SCLC and NSCLC? There are different options for treating lung cancer. The treatment you get depends on the type and stage of your lung cancer, and other factors like your age and ...
Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...
A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.
FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...
DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase inhibitor of the EGFR, which binds irreversibly to certain mutant forms of ...
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback